Press Releases for MLNM

Enter Symbol

Community Research

Stock Sentiment

Whisper Estimates

Enter Estimates

Company Profile

Technical Charts

Analyst Ratings

Analyst Estimates

Sales Estimates

Financial Ratios

Press Releases
Takeda Completes Acquisition of Millennium - May 27 2008 12:42AM
Takeda Completes Subsequent Offering Period for Shares of Millennium Pharmaceuticals, Inc. - May 27 2008 12:42AM
New Analyst Reports for GILEAD SCIENCES INC, ISIS PHARMACEUTICALS INC, CURIS INC, and MILLENNIUM PHARMACEUTICALS INC - May 27 2008 1:18AM
Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period - Jun 2 2008 1:05AM
Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes - Jun 1 2008 5:29PM
Standard & Poor's Announces Changes to U.S. Indices - 05-05-08 - May 27 2008 1:38AM
Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period
Market Pulse Breaking News Alert for Tuesday, April 15, 2008: NCEN - Nacel Energy Deploys Advanced Wind Assessment Systems at Blue Creek and Channing Flats Power Projects!
Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium
BellwetherReport.com Free Analyst Review for MLNM, VMED, FCSX, and APOG
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion

Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia